Aytu Biopharma (AYTU) Gross Profit (QoQ) (2014 - 2026)
Aytu Biopharma (AYTU) Gross Profit (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Aytu Biopharma | 21.86 Mn | -4.85 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.04% |
| Dec 31, 2025 | 4.77% |
| Sep 30, 2025 | -10.42% |
| Jun 30, 2025 | -19.93% |
| Mar 31, 2025 | 18.73% |
| Dec 31, 2024 | -10.00% |
| Sep 30, 2024 | 8.44% |
| Jun 30, 2024 | 6.67% |
| Mar 31, 2024 | -29.05% |
| Dec 31, 2023 | 12.00% |
| Sep 30, 2023 | -29.77% |
| Jun 30, 2023 | 45.68% |
| Mar 31, 2023 | -26.31% |
| Dec 31, 2022 | -4.10% |
| Sep 30, 2022 | 21.49% |
| Jun 30, 2022 | 17.00% |
| Mar 31, 2022 | 3.15% |
| Dec 31, 2021 | -1.26% |
| Sep 30, 2021 | 10.24% |
| Dec 31, 2020 | -5.93% |